New findings reveal why some Chronic Myeloid Leukemia patients respond better to treatment
By alexis [dot] bento_luis [at] med [dot] lu [dot] se (Alexis Luis) - published 7 November 2024 A new study by Lund University researchers suggests that the number of healthy blood stem cells at diagnosis could be an important factor in predicting how well patients with chronic myeloid leukemia will respond to standard therapies. Photo: Getty Images Researchers at Lund University’s Lund Stem Cell